Delivra Health Brands Full Year 2024 Earnings: EPS Beats Expectations
Delivra Health Brands (CVE:DHB) Full Year 2024 Results
Key Financial Results
- Revenue: CA$12.4m (up 26% from FY 2023).
- Net income: CA$876.0k (up from CA$184.0k loss in FY 2023).
- Profit margin: 7.1% (up from net loss in FY 2023).
- EPS: CA$0.003 (up from CA$0.001 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Delivra Health Brands EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) exceeded analyst estimates.
The company's share price is broadly unchanged from a week ago.
Risk Analysis
Be aware that Delivra Health Brands is showing 4 warning signs in our investment analysis and 2 of those are a bit unpleasant...
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSXV:DHB
Delivra Health Brands
Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.
Moderate with mediocre balance sheet.
